Search results
BioLineRx (NASDAQ:BLRX) Upgraded by StockNews.com to Sell
ETF DAILY NEWS· 6 days agoStockNews.com upgraded shares of BioLineRx (NASDAQ:BLRX – Free Report) to a sell rating in a research note published on Tuesday morning. Separately, HC Wainwright restated a buy rating and issued ...
Critical Survey: Coeptis Therapeutics (COEP) versus The Competition
ETF DAILY NEWS· 5 days agoCoeptis Therapeutics (NASDAQ:COEP – Get Free Report) is one of 289 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We ...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Federated Hermes Inc.
ETF DAILY NEWS· 7 days agoFederated Hermes Inc. cut its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure with ...
Jazz Pharmaceuticals (JAZZ) Set to Announce Earnings on Wednesday
ETF DAILY NEWS· 6 days agoJazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce ...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Vontobel Holding Ltd.
ETF DAILY NEWS· 7 days agoVontobel Holding Ltd. lessened its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.0% during the fourth quarter, according to the company in its most recent 13F filing with ...
How Big Pharma Is Taking A Page Out Of Novartis' Playbook
Investor's Business Daily· 5 days agoNovartis (NVS) blazed a trail for treating cancer with targeted radiopharmaceuticals, a treatment that sends radiation directly to cancer cells. Novartis' prostate cancer drug, Pluvicto, which ...